Behbahani Ali

CIK 000161386723 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001613867

Recent Transactions

50 trades

Conversion
SpyGlass Pharma, Inc.$SGP
Series C-2 Preferred Stock
2026-02-09−1,370,168→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series D Preferred Stock
2026-02-09−737,962→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,619,240→ 1,619,240 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,370,168→ 4,359,576 total
Purchase
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09$16.00/sh+937,500→ 6,035,038 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series B Preferred Stock
2026-02-09−402,273→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+954,990→ 954,990 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series A Preferred Stock
2026-02-09−954,990→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series C-1 Preferred Stock
2026-02-09−1,370,168→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+737,962→ 5,097,538 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series B Preferred Stock
2026-02-09−1,619,240→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+402,273→ 1,357,263 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,370,168→ 2,989,408 total
Award
SpyGlass Pharma, Inc.$SGP
Stock Option (right to buy)
2026-02-05+27,400→ 27,400 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series A Convertible Perpetual Preferred Stock
2025-10-02−125,000→ 0 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−280→ 787,979 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+124,085→ 124,085 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+186,128→ 186,128 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+372,255→ 372,255 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−900→ 2,260,970 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+189,195→ 488,982 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+1,656,789→ 1,656,789 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−1,656,789→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−37,700→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−607,536→ 0 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−182→ 2,384,873 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−674,554→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−1,159,683→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+189,195→ 788,259 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−2,384,873→ 0 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−280→ 488,702 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−276→ 674,554 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+124,085→ 2,385,055 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−124,085→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−372,255→ 0 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−2,455→ 1,654,334 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+186,128→ 674,830 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−100,000→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+372,255→ 1,160,234 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series A Convertible Perpetual Preferred Stock
2025-10-02−75,000→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+607,536→ 2,261,870 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−551→ 1,159,683 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−186,128→ 0 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2025-09-19$3.35/sh+4,291→ 81,441 total
Sale
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2025-08-18$0.01/sh−14,671,794→ 0 total
Sale
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2025-08-15$0.01/sh−4,828,206→ 14,671,794 total
Other
Arcellx, Inc.$ACLX
Common Stock
2025-08-12+1,586→ 1,925 total
Other
Arcellx, Inc.$ACLX
Common Stock
2025-08-12+2,621→ 2,706 total

Recent Filings

Address

2855 SAND HILL ROAD

MENLO PARK, CA, 94025

View on SEC.gov